Cytokine activation of antibacterial activity in human pulmonary macrophages: comparison of recombinant interferon-gamma and granulocyte-macrophage colony-stimulating factor
- PMID: 3143484
- DOI: 10.1016/0008-8749(88)90126-8
Cytokine activation of antibacterial activity in human pulmonary macrophages: comparison of recombinant interferon-gamma and granulocyte-macrophage colony-stimulating factor
Abstract
We examined the ability of two recombinant human cytokines, granulocyte-macrophage colony-stimulating factor (rHu-GM-CSF) and interferon-gamma (rHu-IFN-gamma) to activate antibacterial mechanisms in human pulmonary macrophages (PM) and peripheral blood monocytes (PBM). Growth of Legionella pneumophila (LP) was assessed in PM or PBM which had been exposed to either rHu-IFN-gamma (500-1000 u/ml) or rHu-GM-CSF (1 to 10,000 u/ml). In both PM and PBM exposed to 500 u/ml rHu-IFN-gamma, growth of LP was reduced compared to cells exposed to media alone. By comparison, exposure of these cell types to rHu-GM-CSF had no detectable effect on bacterial replication. In order to investigate potential mechanisms accounting for this observation, the effect of these cytokines on the hydrogen peroxide (H2O2)-releasing capacity of cells was studied. Exposure of PM and PBM to rHu-IFN-gamma (500 to 1000 u/ml) resulted in increased production of H2O2 triggered by phorbol myristate acetate; when subjected to the same experimental conditions, rHu-GM-CSF-exposed cells exhibited no increase in H2O2 production. To further clarify the role of rHu-IFN-gamma-induced augmentation of oxidative metabolism on cellular inhibition of bacterial growth, an amount of catalase capable of completely neutralizing extracellular H2O2 was added to cells before and during infection. This did not abrogate the antibacterial activity of rHu-IFN-gamma. These studies demonstrate that rHu-IFN-gamma but not rHu-GM-CSF is capable of augmenting the capacity of PM and PBM to restrict LP growth. These data suggest that the antibacterial activity of rHu-IFN-gamma in this system may involve oxidative as well as nonoxidative mechanisms.
Similar articles
-
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders.Front Immunol. 2023 Jan 5;13:1069444. doi: 10.3389/fimmu.2022.1069444. eCollection 2022. Front Immunol. 2023. PMID: 36685591 Free PMC article. Review.
-
Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.J Exp Med. 1987 Dec 1;166(6):1734-46. doi: 10.1084/jem.166.6.1734. J Exp Med. 1987. PMID: 3119762 Free PMC article.
-
Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase.Ciba Found Symp. 1986;118:211-30. doi: 10.1002/9780470720998.ch14. Ciba Found Symp. 1986. PMID: 3089712 Review.
-
Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis.J Exp Med. 1989 Sep 1;170(3):865-75. doi: 10.1084/jem.170.3.865. J Exp Med. 1989. PMID: 2504878 Free PMC article.
-
Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex.J Leukoc Biol. 1990 Jul;48(1):67-73. doi: 10.1002/jlb.48.1.67. J Leukoc Biol. 1990. PMID: 2113563
Cited by
-
Exogenous and Endogenous Triggers Differentially Stimulate Pigr Expression and Antibacterial Secretory Immunity in the Murine Respiratory Tract.Lung. 2022 Feb;200(1):119-128. doi: 10.1007/s00408-021-00498-8. Epub 2021 Nov 26. Lung. 2022. PMID: 34825965 Free PMC article.
-
Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila.Infect Immun. 1996 Aug;64(8):3236-43. doi: 10.1128/iai.64.8.3236-3243.1996. Infect Immun. 1996. PMID: 8757859 Free PMC article.
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces toxoplasmastatic activity of human monocytes via induction of prostaglandin E2 (PGE2).Clin Exp Immunol. 1995 Nov;102(2):425-9. doi: 10.1111/j.1365-2249.1995.tb03800.x. Clin Exp Immunol. 1995. PMID: 7586701 Free PMC article.
-
Pulmonary macrophages in nosocomial pneumonia: defense function and dysfunction, and prospects for activation.Eur J Clin Microbiol Infect Dis. 1989 Jan;8(1):25-8. doi: 10.1007/BF01964116. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2495947 Review. No abstract available.
-
Future directions for bronchoalveolar lavage.Lung. 1990;168 Suppl:1050-6. doi: 10.1007/BF02718243. Lung. 1990. PMID: 2117106 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials